Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, September 16, 2021 · 551,572,582 Articles · 3+ Million Readers

Benign Prostatic Hyperplasia Treatment Devices And Equipment Industry Trends Include Latest Developments Such As PAE

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report 2021: COVID-19 Impact And Recovery To 2030

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2021: COVID-19 Impact And Recovery To 2030

The Business Research Company’s Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2021: COVID-19 Impact And Recovery

LONDON, GREATER LONDON, UK, August 2, 2021 /EINPresswire.com/ -- Prostatic Astery Embolization (PAE) is one of the latest developments in the benign prostatic hyperplasia treatment market. PAE is a minimally invasive treatment that assists in reducing the symptoms observed in the urinary tract. The PAE procedure is performed using X-rays and other advanced imaging to observe the tumor inside the body and accordingly treat it without any surgery. This technique results in reduced complication in the treatment of BPH and thus is said to be a major development in the BPH treatment market. Leading companies such as Boston Scientific, UNC Healthcare, and Spire Healthcare have been investing in the market for PAE.

Major players in the benign prostatic hyperplasia (BPH) treatment devices and equipment market are Karl Storz, Lumenis, Olympus, Urologix, and Boston Scientific Inc.

Read More On The Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report:
https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

The global benign prostatic hyperplasia (BPH) treatment devices and equipment market is expected to decline from $2.1 billion in 2020 to $2.04 billion in 2021 at a compound annual growth rate (CAGR) of -2.9%. The decline is mainly due to deferment of treatments due to the outbreak of COVID-19 that has led to fall in demand for the equipment. The BPH treatment devices and equipment market is expected to reach $2.73 billion in 2025 at a CAGR of 7.6%.

The market covered in the benign prostatic hyperplasia (BPH) treatment devices and equipment market report is segmented by product into resectoscopes, radiofrequency ablation device, urology lasers, prostatic stents, implants; by end-user into hospitals, ambulatory surgical centers (ASC), clinics, home; by procedure type into transurethral needle ablation (TUNA), transurethral resection of prostate (TURP), transurethral incision of prostate (TUIP), transurethral microwave thermotherapy (TUMT), laser surgery others.

The regions covered in TBRC’s benign prostatic hyperplasia devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2021: COVID-19 Impact And Recovery To 2030 is one of a series of new reports from The Business Research Company that provides benign prostatic hyperplasia (BPH) treatment devices and equipment market overview, forecast benign prostatic hyperplasia (BPH) treatment devices and equipment market size and growth for the whole market, benign prostatic hyperplasia (BPH) treatment devices and equipment market segments, and geographies, benign prostatic hyperplasia (BPH) treatment devices and equipment market trends, benign prostatic hyperplasia (BPH) treatment devices and equipment market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Benign Prostatic Hyperplasia Treatment Devices And Equipment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Drugs For Benign Prostatic Hypertrophy Global Market Report 2021: COVID 19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/drugs-for-benign-prostatic-hypertrophy-global-market-report

Prostate Cancer Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report

Urology Medical Lasers Global Market Report 2021: COVID 19 Growth And Change to 2030
https://www.thebusinessresearchcompany.com/report/urology-medical-lasers-market-report

Interested to know more about The Business Research Company?

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release